The influence of feeding regimens on endogenous digoxin-like immunoreactive substance concentrations in infants

被引:1
|
作者
Kurugol, Z
Ozyurek, R
Levent, E
Parlar, A
Egemen, A
Tuglular, I
机构
[1] Dept. of Pediatrics and Pharmacology, Faculty of Medicine, Ege University, Izmir
[2] Ege Universitesi Tip Fakultesi, Cocuk Sagligi ve Hastaliklari AD, 35100 Bornova, Izmir
关键词
D O I
10.1111/j.1651-2227.1996.tb14140.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The aim of this study was to investigate serum digoxin-like immunoreactive substance (DLIS) levels in 60 healthy term infants when they reached 1-6 months of age with regard to feeding regimen. Group I consisted of 30 infants fed exclusively on breast milk. Groups II and III each consisted of 15 infants fed on formula and cow's milk, and on formula and cow's milk supplemented by breast milk, respectively. Mean serum DLIS concentrations were 0.03 +/- 0.05, 0.18 +/- 0.09 and 0.15 +/- 0.09 ng/ml in groups I-III, respectively. The difference between the DLIS levels in groups II and III was not significant. Serum DLIS levels of infants in groups II and III, on the other hand, were significantly higher than in group I (p < 0.05). These findings were interpreted to suggest that artificial nutrients may cause volume expansion and an increase in endogenous DLIS levels. The latter response is possibly a protective mechanism to decrease volume expansion in groups II and III.
引用
收藏
页码:753 / 754
页数:2
相关论文
共 50 条
  • [1] DIGOXIN-LIKE IMMUNOREACTIVE SUBSTANCE IN RENAL PATIENTS AND IN INFANTS
    DARCY, PF
    PHARMACY INTERNATIONAL, 1984, 5 (07): : 163 - 164
  • [2] SIGNIFICANCE OF THE ENDOGENOUS DIGOXIN-LIKE SUBSTANCE IN INFANTS AND MOTHERS
    KOREN, G
    FARINE, D
    MARESKY, D
    TAYLOR, J
    HEYES, J
    SOLDIN, S
    MACLEOD, S
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (06) : 759 - 764
  • [3] DIGOXIN-LIKE IMMUNOREACTIVE SUBSTANCE IN POSTMORTEM BLOOD OF INFANTS AND CHILDREN
    SPIEHLER, VR
    FISCHER, WR
    RICHARDS, RG
    JOURNAL OF FORENSIC SCIENCES, 1985, 30 (01) : 86 - 91
  • [4] A DIGOXIN-LIKE IMMUNOREACTIVE SUBSTANCE IN PREECLAMPSIA
    GUSDON, JP
    BUCKALEW, VM
    HENNESSY, JF
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1984, 150 (01) : 83 - 85
  • [5] DIGOXIN-LIKE IMMUNOREACTIVE SUBSTANCE IN PREGNANCY
    GONZALEZ, AR
    PHELPS, SJ
    COCHRAN, EB
    SIBAI, BM
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1987, 157 (03) : 660 - 664
  • [6] TENTATIVE IDENTIFICATION OF A DIGOXIN-LIKE IMMUNOREACTIVE SUBSTANCE
    TOSELAND, PA
    OLDFIELD, PR
    MURPHY, GM
    LAWSON, AM
    THERAPEUTIC DRUG MONITORING, 1988, 10 (02) : 168 - 171
  • [7] PERINATAL CHANGES IN A DIGOXIN-LIKE IMMUNOREACTIVE SUBSTANCE
    SECCOMBE, DW
    PUDEK, MR
    WHITFIELD, MF
    JACOBSON, BE
    WITTMANN, BK
    KING, JF
    PEDIATRIC RESEARCH, 1984, 18 (11) : 1097 - 1099
  • [8] URINARY DIGOXIN-LIKE IMMUNOREACTIVE SUBSTANCE IN PREGNANCY
    GOODLIN, RC
    AMERICAN JOURNAL OF MEDICINE, 1988, 84 (03): : 564 - 564
  • [9] Digoxin-like immunoreactive substance in nonoliguric hyperkalemia
    Mildenberger, E
    Oels, K
    Bauer, K
    Paul, M
    Versmold, HT
    PEDIATRIC RESEARCH, 2002, 52 (05) : 787 - 787
  • [10] RELATION OF DIGOXIN-LIKE IMMUNOREACTIVE SUBSTANCE TO PREECLAMPSIA
    FRIEDMAN, HS
    XENAKIS, E
    VORPERIAN, V
    BABB, B
    FARRER, S
    TRICOMI, V
    CLINICAL RESEARCH, 1989, 37 (03): : A854 - A854